BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 34957101)

  • 21. Prognostic value of the ratio of ground glass opacity on computed tomography in small lung adenocarcinoma: A meta-analysis.
    Miao XH; Yao YW; Yuan DM; Lv YL; Zhan P; Lv TF; Liu HB; Song Y
    J Thorac Dis; 2012 Jun; 4(3):265-71. PubMed ID: 22754665
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pure ground-glass opacity on chest computed tomography: predictive factors for invasive adenocarcinoma.
    Moon Y; Sung SW; Lee KY; Sim SB; Park JK
    J Thorac Dis; 2016 Jul; 8(7):1561-70. PubMed ID: 27499944
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical features and surgical outcomes of young patients with lung adenocarcinoma manifesting as ground glass opacity.
    Qu R; Tu D; Cai Y; Ping W; Fu X
    Front Oncol; 2022; 12():979522. PubMed ID: 36185186
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Impact of the International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society classification of stage IA adenocarcinoma of the lung: Correlation between computed tomography images and EGFR and KRAS gene mutations.
    Wang T; Zhang T; Han X; Liu XI; Zhou N; Liu Y
    Exp Ther Med; 2015 Jun; 9(6):2095-2103. PubMed ID: 26136941
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A Machine-Learning Approach to Developing a Predictive Signature Based on Transcriptome Profiling of Ground-Glass Opacities for Accurate Classification and Exploring the Immune Microenvironment of Early-Stage LUAD.
    Zhao Z; Yin W; Peng X; Cai Q; He B; Shi S; Peng W; Tu G; Li Y; Li D; Tao Y; Peng M; Wang X; Yu F
    Front Immunol; 2022; 13():872387. PubMed ID: 35693786
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Undetectable circulating tumor DNA levels correlate with low risk of recurrence/metastasis in postoperative pathologic stage I lung adenocarcinoma patients.
    Yang W; You N; Jia M; Yeung SJ; Ou W; Yu M; Wang Y; Fu X; Zhang Z; Yang J; Lao Z; Liu Z; Zeng B; Ou Q; Wu X; Shao YW; Hong X; Wang S; Cheng C
    Lung Cancer; 2020 Aug; 146():327-334. PubMed ID: 32623075
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long-term results after surgical treatment of the dominant lung adenocarcinoma associated with ground-glass opacities.
    Bongiolatti S; Corzani R; Borgianni S; Meniconi F; Cipollini F; Gonfiotti A; Viggiano D; Paladini P; Voltolini L
    J Thorac Dis; 2018 Aug; 10(8):4838-4848. PubMed ID: 30233857
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Genetic characteristics of lung adenocarcinoma with ground-glass opacity component.
    Zhu W; Bai N; Cao J; Yang F; Chen D
    J Thorac Dis; 2023 Nov; 15(11):6106-6114. PubMed ID: 38090297
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pathological and radiological T descriptors in invasive lung adenocarcinoma: from correlations to prognostic significance.
    Ma Z; Han H; Cao H; Wang S; Li Y; Zhang Y; Chen H
    Transl Lung Cancer Res; 2023 Nov; 12(11):2181-2192. PubMed ID: 38090517
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prognostic impact of nomogram based on whole tumour size, tumour disappearance ratio on CT and SUVmax on PET in lung adenocarcinoma.
    Song SH; Ahn JH; Lee HY; Lee G; Choi JY; Kang J; Kim EY; Han J; Kwon OJ; Lee KS; Kim HK; Choi YS; Kim J; Shim YM
    Eur Radiol; 2016 Jun; 26(6):1538-46. PubMed ID: 26455720
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Predictors of Pathologic Tumor Invasion and Prognosis for Ground Glass Opacity Featured Lung Adenocarcinoma.
    Ye T; Deng L; Xiang J; Zhang Y; Hu H; Sun Y; Li Y; Shen L; Wang S; Xie L; Chen H
    Ann Thorac Surg; 2018 Dec; 106(6):1682-1690. PubMed ID: 30096292
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Risk factors for lymph node metastasis and surgical methods in patients with early-stage peripheral lung adenocarcinoma presenting as ground glass opacity.
    Wang Y; Jing L; Wang G
    J Cardiothorac Surg; 2020 Aug; 15(1):121. PubMed ID: 32782020
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pathological features and prognostic implications of ground-glass opacity components on computed tomography for clinical stage I lung adenocarcinoma.
    Katsumata S; Aokage K; Ishii G; Hoshino H; Suzuki J; Miyoshi T; Tane K; Samejima J; Tsuboi M
    Surg Today; 2021 Jul; 51(7):1188-1202. PubMed ID: 33745094
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Micropapillary or solid component predicts worse prognosis in pathological IA stage lung adenocarcinoma: A meta-analysis.
    Wang Y; Hu J; Sun Y; Lu Y
    Medicine (Baltimore); 2023 Dec; 102(49):e36503. PubMed ID: 38065873
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prognostic influence of a ground-glass opacity component in hypermetabolic lung adenocarcinoma.
    Hattori A; Matsunaga T; Fukui M; Takamochi K; Suzuki K
    Eur J Cardiothorac Surg; 2022 Jan; 61(2):249-256. PubMed ID: 34632486
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinicopathological characteristics and prognosis of non-lepidic invasive adenocarcinoma presenting as ground glass opacity nodule.
    Moon Y; Sung SW; Lee KY; Park JK
    J Thorac Dis; 2016 Sep; 8(9):2562-2570. PubMed ID: 27747010
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Influence of Ground Glass Opacity and the Corresponding Pathological Findings on Survival in Patients with Clinical Stage I Non-Small Cell Lung Cancer.
    Aokage K; Miyoshi T; Ishii G; Kusumoto M; Nomura S; Katsumata S; Sekihara K; Tane K; Tsuboi M
    J Thorac Oncol; 2018 Apr; 13(4):533-542. PubMed ID: 29246833
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Correlation in histological subtypes with high resolution computed tomography signatures of early stage lung adenocarcinoma.
    Miao Y; Zhang J; Zou J; Zhu Q; Lv T; Song Y
    Transl Lung Cancer Res; 2017 Feb; 6(1):14-22. PubMed ID: 28331820
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prognostic significance and survival benefits of postoperative adjuvant chemotherapy in patients with stage IA lung adenocarcinoma with non-predominant micropapillary components.
    Li R; Qiu J; Li Z; Li H; Tang Z; Yu W; Tian H; Sun Z
    World J Surg Oncol; 2024 Jan; 22(1):32. PubMed ID: 38273367
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Long-term outcomes of wedge resection for pulmonary ground-glass opacity nodules.
    Cho JH; Choi YS; Kim J; Kim HK; Zo JI; Shim YM
    Ann Thorac Surg; 2015 Jan; 99(1):218-22. PubMed ID: 25440277
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.